146 related articles for article (PubMed ID: 35255463)
21. Prevalence of Depressive Symptoms in Patients with Type 1 and 2 Diabetes Mellitus.
Bąk E; Marcisz-Dyla E; Młynarska A; Sternal D; Kadłubowska M; Marcisz C
Patient Prefer Adherence; 2020; 14():443-454. PubMed ID: 32184573
[TBL] [Abstract][Full Text] [Related]
22. Hope and mealtime insulin boluses are associated with depressive symptoms and glycemic control in youth with type 1 diabetes mellitus.
Calkins-Smith AK; Marker AM; Clements MA; Patton SR
Pediatr Diabetes; 2018 Nov; 19(7):1309-1314. PubMed ID: 29797445
[TBL] [Abstract][Full Text] [Related]
23. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
24. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
[TBL] [Abstract][Full Text] [Related]
25. Insulin therapy in children and adolescents with type 1 diabetes.
Malik FS; Taplin CE
Paediatr Drugs; 2014 Apr; 16(2):141-50. PubMed ID: 24458650
[TBL] [Abstract][Full Text] [Related]
26. The impact of anxiety and depression on patients within a large type 1 diabetes insulin pump population. An observational study.
Grant P; Dworakowska D; DeZoysa N; Barnes D
Diabetes Metab; 2013 Oct; 39(5):439-44. PubMed ID: 24076359
[TBL] [Abstract][Full Text] [Related]
27. [Changes in fasting serum cortisol levels in adolescents with type 1 diabetes and elevated depressive symptoms].
Wen YJ; Guo J; Zhou ZG; Luo ZQ; He GP
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Oct; 17(10):1098-102. PubMed ID: 26483232
[TBL] [Abstract][Full Text] [Related]
28. Reliability and validity of the Diabetes Eating Problem Survey in Greek adults with type 1 diabetes mellitus.
Apergi Κ; Romanidou Μ; Abdelkhalek Η; Tripsianis G; Gonidakis F
Psychiatriki; 2020; 31(4):310-320. PubMed ID: 33361061
[TBL] [Abstract][Full Text] [Related]
29. Managing Type 1 Diabetes among Saudi adults on insulin pump therapy during the COVID-19 lockdown.
Magliah SF; Zarif HA; Althubaiti A; Sabban MF
Diabetes Metab Syndr; 2021; 15(1):63-68. PubMed ID: 33310178
[TBL] [Abstract][Full Text] [Related]
30. Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review.
Alsaleh FM; Smith FJ; Taylor KM
J Clin Pharm Ther; 2012 Apr; 37(2):140-7. PubMed ID: 21729118
[TBL] [Abstract][Full Text] [Related]
31. Insulin pump therapy: impact on the lives of children/young people with diabetes mellitus and their parents.
Alsaleh FM; Smith FJ; Thompson R; Al-Saleh MA; Taylor KM
Int J Clin Pharm; 2014 Oct; 36(5):1023-30. PubMed ID: 25108411
[TBL] [Abstract][Full Text] [Related]
32. Parental Stress, Anxiety and Depression Symptoms Associated with Self-Efficacy in Paediatric Type 1 Diabetes: A Literature Review.
Bassi G; Mancinelli E; Di Riso D; Salcuni S
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33379307
[No Abstract] [Full Text] [Related]
33. Depressive Symptoms at Critical Times in Youth With Type 1 Diabetes: Following Type 1 Diabetes Diagnosis and Insulin Pump Initiation.
McGill DE; Volkening LK; Pober DM; Muir AB; Young-Hyman DL; Laffel LM
J Adolesc Health; 2018 Feb; 62(2):219-225. PubMed ID: 29212599
[TBL] [Abstract][Full Text] [Related]
34. Alexithymia, intolerance to uncertainty and mental health difficulties in adolescents with Type 1 diabetes mellitus.
Merlo EM; Tutino R; Myles LAM; Lia MC; Minasi D
Ital J Pediatr; 2024 May; 50(1):99. PubMed ID: 38755698
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of physical activity against health risks associated with type 1 diabetes: "Health benefits outweigh the risks".
Wake AD
World J Diabetes; 2022 Mar; 13(3):161-184. PubMed ID: 35432757
[TBL] [Abstract][Full Text] [Related]
36. Technological Developments and Quality of Life in Type 1 Diabetes Mellitus Patients: A Review of the Modern Insulin Analogues, Continuous Glucose Monitoring and Insulin Pump Therapy.
Benioudakis E; Karlafti E; Kalaitzaki A; Kaiafa G; Savopoulos C; Didangelos T
Curr Diabetes Rev; 2022; 18(7):e031121197657. PubMed ID: 34732118
[TBL] [Abstract][Full Text] [Related]
37. Continuous subcutaneous insulin infusion therapy for Type 1 diabetes mellitus in children.
Mavinkurve M; Quinn A; O'Gorman CS
Ir J Med Sci; 2016 May; 185(2):335-40. PubMed ID: 27083461
[TBL] [Abstract][Full Text] [Related]
38. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
[TBL] [Abstract][Full Text] [Related]
39. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
